The Supreme Court's Constitutional Bench resumed its hearing over the appeals against the trial of civilians in military courts, during which Justice Musarat Hilali has questioned the difference ...
NEW YORK (AP) — A New York judge set a March 2026 trial date on Monday and moved an initial conference from mid-February to next week as the public feud between Blake Lively and her “It Ends ...
It ends in court — next year. Blake Lively and Justin Baldoni are headed to trial on March 9, 2026 to settle their “It Ends With Us” legal dispute. The court date for the case was scheduled ...
Apollo Global Management Inc. is also among firms interested in the senior debt, which is being sold by a group of banks led by Morgan Stanley, said the people, who declined to be identified ...
The pre-pivotal clinical trial, which included 30 diabetic participants—primarily individuals with Type 1 diabetes—represents a significant milestone in Trinity's mission to deliver affordable ...
Judge Lewis J. Liman scheduled a trial date for Blake Lively and Justin Baldoni's lawsuits Benjamin VanHoose is a Staff Editor on the Movies team at PEOPLE. He has written about entertainment and ...
The Jedi stand ready in your first look at the final book of Star Wars: The High Republic's third phase, Trial of the Jedi. It’s been nearly five years since we heard about one of the boldest ...
Since the pandemic, drug trials that purposely make people vomit, shiver and ache have become a research area of growing interest. All that’s needed: brave volunteers. Credit...Jon Han Supported ...
A Phase III trial demonstrated that adding nivolumab, an immunotherapy drug, to pre-surgery chemotherapy significantly improves cure rates for ER+/HER2− breast cancer, the most common subtype.
On this date, Jan. 27, 1967, NASA astronauts Virgil “Gus” Grissom, Edward White and Roger Chaffee died during a pre-launch test for Apollo 1. A flash fire swept through the capsule so quickly ...
Europe's largest pharmaceutical firm, Novo Nordisk, revealed positive trial results for its next-generation obesity drug, amycretin, marking a major step in its competition within the increasingly ...